Filing Details
REPLIGEN CORP (NASDAQ:RGEN) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event.
8k filedNASDAQ:RGEN
REPLIGEN CORP (RGEN) Reports Material Event to SEC
Filing Details REPLIGEN CORP (NASDAQ:RGEN) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event. Market Context REPLIGEN…
Market Context
REPLIGEN CORP's stock currently trades at $140.09 with a market capitalization of $9.1B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for REPLIGEN CORP's stock.
All SEC filings for REPLIGEN CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RGEN Stock Page
Frequently Asked Questions
Where can I read RGEN's SEC filings?
Browse all filings on our RGEN SEC filings page.
What types of SEC filings does REPLIGEN CORP file?
Public companies like REPLIGEN CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.